<DOC>
	<DOCNO>NCT02140268</DOCNO>
	<brief_summary>A Study Evaluate Effects oral repeat dos AZD1722 Pharmacokinetics Oral Midazolam Healthy Volunteers</brief_summary>
	<brief_title>To Evaluate Effect AZD1722 Pharmacokinetics Oral Midazolam Healthy Volunteers</brief_title>
	<detailed_description>A Phase 1 , Single-center , Fixed-sequence , Open Label Study Evaluate Effect Oral Repeated Doses AZD1722 Pharmacokinetics Oral Midazolam Healthy Volunteers</detailed_description>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Have body mass index ( BMI ) ≥18 ≤30 kg/m2 weigh least 50 kg 100 kg . Females nonchildbearing potential must postmenopausal defined amenorrhea least 12 month follow cessation exogenous hormonal treatment follicle stimulate hormone ( FSH ) level postmenopausal range documentation irreversible surgical sterilization hysterectomy , bilateraloophorectomy bilateral salpingectomy tubal ligation Females childbearing potential must negative pregnancy test screening , Day 1 , Day 14 must lactate use effective contraceptive method avoid pregnancy treatment period Male healthy volunteer partner childbearing potential must agree avoid father child , refrain donate sperm , first day dose least 3 month last dose investigational product , therefore either sterile agree use approve method contraception History clinically significant disease disorder , opinion principal investigator , may either put healthy volunteer risk participation study , influence result healthy volunteer 's ability participate study . History presence GI , hepatic renal disease include GI surgery appendectomy condition know interfere absorption , distribution , metabolism excretion drug . Loose stool ( BSFS 6 7 ) ≥2 day past 7 day investigational product administration . Use medication know affect stool consistency and/or GI motility , include fiber supplement , antidiarrheal , prokinetic drug , enema , probiotic medication supplement , salt electrolyte supplement contain sodium , potassium , chloride , bicarbonate formulation past 7 day investigational product administration . Use prescribed nonprescribed medication include antacid , analgesic paracetamol/acetaminophen , herbal remedy , vitamin mineral 2 week prior first administration investigational product long medication long halflife . Use drug substance enzymeinducing property within 4 week prior first administration investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Healthy</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>